Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Type (HIV, Hepatitis), By Treatment (Antibacterial, Antifungal Drugs), By Region - Industry Forecast 2025-2032

Infectious Disease Therapeutics Market size was valued at USD 119.86 Billion in 2023 and is poised to grow from USD 124.93 Billion in 2024 to USD 174.03 Billion by 2032, growing at a CAGR of 4.23% during the forecast period (2025-2032).

Infectious disease is a major cause of significant pressure in the global healthcare industry. These diseases, also known as transmissible or communicable diseases, are caused by a variety of infectious agents such as viruses, viroids, and bacteria. The introduction of various technologically advanced diagnosis and treatment options, as well as advancements in hygiene, vaccination, and antimicrobial therapy, have reduced the number of deaths caused by infectious diseases. However, the rise and re-emergence of infectious diseases have a significant impact on the global population's health outcomes. The infectious disease therapeutics market is anticipated to grow significantly over the forecast period, attributed to rising infectious disease occurrence, increased awareness about early infectious disease diagnosis, and increased research funding activities by various private and government organisations. However, the high cost of treating infectious diseases with highly developed medicines severely restricts market growth by putting additional strain on people's disposable income. The market's increasing demand for generic drugs has also hampered the growth of labelled drugs that treat infectious diseases.

US Infectious Disease Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.